Lumida
/COGT
⌘K
Cogent Biosciences Inc

Cogent Biosciences Inc

COGT
$33.41USD-1.97%-0.67 today

MARKET CAP

5.8B

P/E (TTM)

FWD P/E

DAY RANGE

$33 – $35

52W RANGE

$12
$44

AI Summary

Stalk
Sell NowMedium

COGT is in Stage 3 distribution after a decisive support failure and Bearish Pivot Point, establishing a bearish medium-term bias. Price trades below declining EMAs and rejects rallies into the 9/20 EMA region, justifying immediate sell-side engagement. Extreme oversold conditions introduce risk of a relief bounce, but the downtrend remains intact until key support breaks.

  • Phase 3 PEAK trial showed 50% lower progression risk.
  • Three NDAs pending; two under FDA priority review late 2026.
  • Q2 ’26 net loss $96.4M (+31.7% YoY); profitability remains negative.
Full analysis →

Buying

10

institutions

Selling

8

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY17.35 M671.55 M+1.31 M+8.7%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY11.93 M459.27 M+7.39 M+185.1%0.11%
WP

Woodline Partners LP

Q2 2026

SELL2.60 M100.74 M+-415.95 K-13.3%0.31%
RI

Rtw Investments, LP

Q2 2026

SELL2.31 M89.36 M+-3.15 M-57.5%0.76%
CA

Citadel Advisors LLC

Q2 2026

SELL1.07 M41.51 M+-834.73 K-43.5%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY1.05 M40.82 M+198.25 K+23.8%0.05%
RT

Renaissance Technologies LLC

Q2 2026

BUY996.17 K38.55 M+289.90 K+41.8%0.05%
MM

Millennium Management LLC

Q2 2026

SELL907.71 K35.13 M+-284.69 K-23.5%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL744.20 K28.80 M+-666.63 K-47.0%0.03%
EP

Eversept Partners, LP

Q2 2026

BUYNEW490.24 K18.97 M+490.24 K+0.0%0.98%
AC

Aqr Capital Management LLC

Q2 2026

BUY294.91 K11.41 M+105.12 K+56.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL258.95 K10.31 M+-3.75 K+10.9%0.00%
FA

Fisher Asset Management, LLC

Q2 2026

BUY184.88 K7.15 M+17.46 K+11.0%0.00%
MG

Man Group Plc

Q2 2026

SELL167.86 K6.50 M+-26.94 K-13.4%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL121.08 K4.69 M+-121.08 K-49.7%0.07%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY68.94 K2.67 M+63.74 K+1232.8%0.02%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW17.00 K657.90 K+17.00 K+0.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUYNEW12.20 K472.14 K+12.20 K+0.0%0.02%